Statistics
Publications
28
Citations
6.1K
H-Index
22
Active since
1975
Peter Chin is an author at Novartis (Switzerland) specializing in neurology, multiple sclerosis, and multiple sclerosis pharmacotherapy.
Publications per year
1975–2023
28
28
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Stephen L. Hauser, Amit Bar‐Or, Gavin Giovannoni et al. · New England Journal of Medicine · 2016 · 2K citations · Full text
Life Sciences, Immunology, Neurology +17
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
Xavier Montalbán, Stephen L. Hauser, Ludwig Kappos et al. · New England Journal of Medicine · 2016 · 1.9K citations · Full text
Life Sciences, Immunology, Neurology +17
Xilin Liu, Milin Zhang, Tao Xiong et al. · IEEE Transactions on Biomedical Circuits and Systems · 2016 · 146 citations
1–5 of 28